ATE422944T1 - Superoxiddismutas-mimetika zur behandlung von augenerkrankungen - Google Patents
Superoxiddismutas-mimetika zur behandlung von augenerkrankungenInfo
- Publication number
- ATE422944T1 ATE422944T1 AT02786915T AT02786915T ATE422944T1 AT E422944 T1 ATE422944 T1 AT E422944T1 AT 02786915 T AT02786915 T AT 02786915T AT 02786915 T AT02786915 T AT 02786915T AT E422944 T1 ATE422944 T1 AT E422944T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- mimetics
- eye diseases
- dismutas
- superoxide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34038901P | 2001-12-14 | 2001-12-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE422944T1 true ATE422944T1 (de) | 2009-03-15 |
Family
ID=23333158
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02786915T ATE422944T1 (de) | 2001-12-14 | 2002-12-06 | Superoxiddismutas-mimetika zur behandlung von augenerkrankungen |
Country Status (19)
Country | Link |
---|---|
US (2) | US7759333B2 (de) |
EP (1) | EP1463563B1 (de) |
JP (1) | JP2005513063A (de) |
KR (1) | KR100951606B1 (de) |
CN (2) | CN101092432A (de) |
AT (1) | ATE422944T1 (de) |
BR (1) | BR0214957A (de) |
CA (1) | CA2470721C (de) |
CY (1) | CY1108983T1 (de) |
DE (1) | DE60231246D1 (de) |
DK (1) | DK1463563T3 (de) |
ES (1) | ES2319399T3 (de) |
HK (1) | HK1069785A1 (de) |
MX (1) | MXPA04005601A (de) |
PL (1) | PL210225B1 (de) |
PT (1) | PT1463563E (de) |
SI (1) | SI1463563T1 (de) |
WO (1) | WO2003051458A1 (de) |
ZA (1) | ZA200404435B (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7759333B2 (en) * | 2001-12-14 | 2010-07-20 | Alcon, Inc. | Superoxide dismutase mimics for the treatment of ocular disorders and diseases |
AU2004305531B2 (en) * | 2003-12-11 | 2009-11-26 | Alcon, Inc. | Superoxide dismutase mimics for the treatment of optic nerve and retinal damage |
US7803931B2 (en) | 2004-02-12 | 2010-09-28 | Archemix Corp. | Aptamer therapeutics useful in the treatment of complement-related disorders |
US8598150B1 (en) | 2008-04-02 | 2013-12-03 | Jonathan R. Brestoff | Composition and method for affecting obesity and related conditions |
US8987245B2 (en) | 2008-04-02 | 2015-03-24 | Jonathan R. Brestoff Parker | Composition and method for affecting obesity and related conditions |
US8114893B2 (en) | 2008-12-19 | 2012-02-14 | Genentech, Inc. | Compounds and methods of use |
PT2433640T (pt) | 2010-09-24 | 2020-04-03 | Omnivision Gmbh | Composição compreendendo sod, luteína e zeaxantina |
KR101214364B1 (ko) * | 2011-02-15 | 2012-12-21 | 한림대학교 산학협력단 | 수퍼옥사이드 디스뮤테이즈 융합 단백질을 함유하는 안과 질환 예방 또는 치료용 약제학적 조성물 |
CN111467351A (zh) * | 2011-09-26 | 2020-07-31 | 加莱拉实验室有限责任公司 | 用于治疗疾病的方法 |
KR102531246B1 (ko) * | 2021-12-23 | 2023-05-11 | 주식회사 제노포커스 | 수퍼옥시드 디스뮤타제 및 이의 건성 황반변성의 예방 또는 치료용 용도 |
WO2023224136A1 (ko) * | 2022-05-16 | 2023-11-23 | 주식회사 제노포커스 | 수퍼옥시드 디스뮤타제 및 이의 당뇨망막병증 또는 포도막염의 예방 또는 치료용 용도 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5209926A (en) * | 1990-06-12 | 1993-05-11 | Insite Vision Incorporated | Aminosteroids for ophthalmic use |
US5124154A (en) * | 1990-06-12 | 1992-06-23 | Insite Vision Incorporated | Aminosteroids for ophthalmic use |
US5994339A (en) * | 1993-10-15 | 1999-11-30 | University Of Alabama At Birmingham Research Foundation | Oxidant scavengers |
US6127356A (en) * | 1993-10-15 | 2000-10-03 | Duke University | Oxidant scavengers |
SE9402816D0 (sv) | 1994-08-24 | 1994-08-24 | Pharmacia Ab | Method and meams for drug administration |
US6180620B1 (en) | 1997-06-20 | 2001-01-30 | G.D. Searle & Co. | Analgesic methods using synthetic catalysts for the dismutation of superoxide radicals |
US6214817B1 (en) * | 1997-06-20 | 2001-04-10 | Monsanto Company | Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
EP1045851B1 (de) * | 1997-11-03 | 2003-04-23 | Duke University | Substituierte porphyrinen |
AU5251999A (en) | 1998-08-04 | 2000-02-28 | Wisconsin Alumni Research Foundation | Method of reducing retinal ganglion cell degeneration |
GB9817845D0 (en) * | 1998-08-17 | 1998-10-14 | Glaxo Group Ltd | Chemical compounds |
WO2000023568A2 (en) | 1998-10-06 | 2000-04-27 | Albert Einstein College Of Medicine Of Yeshiva University | Methods and compositions for decreasing mitochondrial overproduction of reactive oxygen species in cells |
WO2000072893A2 (en) | 1999-05-27 | 2000-12-07 | Monsanto Company | Biomaterials modified with superoxide dismutase mimics |
US7759333B2 (en) * | 2001-12-14 | 2010-07-20 | Alcon, Inc. | Superoxide dismutase mimics for the treatment of ocular disorders and diseases |
-
2002
- 2002-12-06 US US10/498,721 patent/US7759333B2/en not_active Expired - Fee Related
- 2002-12-06 EP EP02786915A patent/EP1463563B1/de not_active Expired - Lifetime
- 2002-12-06 CA CA2470721A patent/CA2470721C/en not_active Expired - Fee Related
- 2002-12-06 JP JP2003552386A patent/JP2005513063A/ja active Pending
- 2002-12-06 CN CNA2006100774968A patent/CN101092432A/zh active Pending
- 2002-12-06 KR KR1020047008842A patent/KR100951606B1/ko not_active IP Right Cessation
- 2002-12-06 DK DK02786915T patent/DK1463563T3/da active
- 2002-12-06 DE DE60231246T patent/DE60231246D1/de not_active Expired - Lifetime
- 2002-12-06 MX MXPA04005601A patent/MXPA04005601A/es active IP Right Grant
- 2002-12-06 ES ES02786915T patent/ES2319399T3/es not_active Expired - Lifetime
- 2002-12-06 PT PT02786915T patent/PT1463563E/pt unknown
- 2002-12-06 BR BR0214957-5A patent/BR0214957A/pt not_active Application Discontinuation
- 2002-12-06 CN CNA028280806A patent/CN1620325A/zh active Pending
- 2002-12-06 AT AT02786915T patent/ATE422944T1/de active
- 2002-12-06 SI SI200230808T patent/SI1463563T1/sl unknown
- 2002-12-06 WO PCT/US2002/039037 patent/WO2003051458A1/en active IP Right Grant
- 2002-12-06 PL PL369607A patent/PL210225B1/pl unknown
-
2004
- 2004-06-04 ZA ZA200404435A patent/ZA200404435B/en unknown
-
2005
- 2005-03-17 HK HK05102326.6A patent/HK1069785A1/xx not_active IP Right Cessation
-
2009
- 2009-04-14 CY CY20091100442T patent/CY1108983T1/el unknown
-
2010
- 2010-04-23 US US12/766,332 patent/US8003635B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20100204194A1 (en) | 2010-08-12 |
KR100951606B1 (ko) | 2010-04-09 |
BR0214957A (pt) | 2004-12-14 |
WO2003051458A1 (en) | 2003-06-26 |
PT1463563E (pt) | 2009-03-19 |
KR20040063943A (ko) | 2004-07-14 |
DK1463563T3 (da) | 2009-04-20 |
US7759333B2 (en) | 2010-07-20 |
US8003635B2 (en) | 2011-08-23 |
ES2319399T3 (es) | 2009-05-07 |
US20050032768A1 (en) | 2005-02-10 |
CA2470721A1 (en) | 2003-06-26 |
HK1069785A1 (en) | 2005-06-03 |
CA2470721C (en) | 2011-07-12 |
ZA200404435B (en) | 2006-05-31 |
EP1463563A1 (de) | 2004-10-06 |
EP1463563B1 (de) | 2009-02-18 |
JP2005513063A (ja) | 2005-05-12 |
PL210225B1 (pl) | 2011-12-30 |
CN1620325A (zh) | 2005-05-25 |
MXPA04005601A (es) | 2004-12-06 |
SI1463563T1 (sl) | 2009-06-30 |
PL369607A1 (en) | 2005-05-02 |
AU2002351267B2 (en) | 2007-04-05 |
AU2002351267A1 (en) | 2003-06-30 |
DE60231246D1 (de) | 2009-04-02 |
CN101092432A (zh) | 2007-12-26 |
CY1108983T1 (el) | 2014-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1108983T1 (el) | Μιμητικα της υπεροξειδικης δισμουτασης για την αγωγη οφθαλμικων διαταραχων και νοσων | |
ATE539701T1 (de) | Zusammengesetzte schlinge zur behandlung von inkontinenz | |
BR0317026A (pt) | Mìmicos de superóxido dismutase para o tratamento de distúrbios e doenças oculares | |
ATE254461T1 (de) | Behandlung von augenschmerzen | |
ATE468137T1 (de) | Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten | |
DE60019473D1 (de) | (S,S)-Reboxetin zur Behandlung von peripheren Neuropathien | |
DE60204466D1 (de) | Integrinhemmer zur behandlung von augenkrankheiten | |
ATE466585T1 (de) | Präparationen grampositiver bakterien zur behandlung von krankheiten mit immunfehlregulation | |
DE60218153D1 (de) | Verwendung von proteasom-inhibitoren zur behandlung des trockenen auges | |
TR200101149T2 (tr) | Dış retina bozukluklarının tedavisi. | |
ATE448779T1 (de) | Methode zur behandlung trockener augen und uveitis | |
ATE383874T1 (de) | Perylenequinonen zur anwendung als sonosensitizer | |
ATE258793T1 (de) | 5-ht2 agonisten als mittel zur kontrolle des augeninnendrucks und zur behandlung von glaukom | |
ATE487482T1 (de) | Superoxid-dismutase-mimika zur behandlungvon augenstörungen und erkrankungen | |
DE60138385D1 (de) | Heilmittel zur behandlung von erkrankungen des sehnervs | |
ATE253936T1 (de) | Glutathion-reduktase zur behandlung und prophylaxe von aids | |
ATE541566T1 (de) | Zusammensetzungen zur behandlung von erkrankungen der augenoberfläche | |
DE60109594D1 (de) | R-eliprodil zur behandlung von glaucoma | |
ATE343387T1 (de) | S-methyl-dihydro-ziprasidon zur behandlung von augenerkrankungen. | |
ATE443060T1 (de) | Benzoägüchinolinderivate zur behandlung von glaucom und kurzsichtigkeit | |
MXPA04001255A (es) | Uso de compuesto para el tratamiento de condiciones que resultan de lesion al nervio corneo despues de lasik y otras cirugias oculares o trauma. | |
BRPI0417549A (pt) | miméticos de superóxido dismutase para o tratamento de lesão de nervo óptico e retinal | |
ATE344054T1 (de) | Behandlung von okularen neovaskularen erkrankungen | |
ATE412423T1 (de) | Peroxiredoxin-arzneistoffe zur behandlung einer hiv-1-infektion | |
DE60234031D1 (de) | Mittel zur behandlung allergischer augenerkrankungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1463563 Country of ref document: EP |